InvestorsHub Logo

tredenwater2

12/17/21 10:37 AM

#340360 RE: couldbebetter #340359

He and his cronies must be loaded up!

LakeshoreLeo1953

12/17/21 10:44 AM

#340365 RE: couldbebetter #340359

Had already made similar statement earlier this week.

Package that with UK just blasting BIIB and you have
at least visibility possible for AVXL.

end2war

12/17/21 11:40 AM

#340381 RE: couldbebetter #340359

When I looked at their trials some time ago, I concluded LLY has better trial results than Adhelm with the amyloid hypothesis, and they will prove that you can slow the decline in some patients, with that approach.

Their are reasons that the FDA granted BIIB approval, and I believe it was based in part on FDA information about potential benifits of clearing some parts of the amyloid cascade. Not all amyloid is the same.

BIIB has another drug focused on this approach that may work better than Adhelm which also merits attention.

FitzyP33

12/17/21 12:06 PM

#340384 RE: couldbebetter #340359

Hmmm. Cramer was not on squawk on the street this morning. Said he was off today.

HadToHavit

12/17/21 12:11 PM

#340385 RE: couldbebetter #340359

Funny. AVXL Up 5%
LLY down 5%. Go figure

RedShoulder

12/17/21 12:20 PM

#340386 RE: couldbebetter #340359

Cramer just stated on CNBC that LLY's Alzheimers drug works!



WS connects told him to pump LLY.

How much Alzheimer due diligence did he put into it? It probably could be measured in seconds.